ATE231725T1 - Pharmazeutische zubereitungen zur oralen verabreichung von molekulares jod - Google Patents
Pharmazeutische zubereitungen zur oralen verabreichung von molekulares jodInfo
- Publication number
- ATE231725T1 ATE231725T1 AT98954002T AT98954002T ATE231725T1 AT E231725 T1 ATE231725 T1 AT E231725T1 AT 98954002 T AT98954002 T AT 98954002T AT 98954002 T AT98954002 T AT 98954002T AT E231725 T1 ATE231725 T1 AT E231725T1
- Authority
- AT
- Austria
- Prior art keywords
- iodine
- mammal
- molecular iodine
- molecular
- oral administration
- Prior art date
Links
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 title abstract 5
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 5
- 229910052740 iodine Inorganic materials 0.000 abstract 5
- 239000011630 iodine Substances 0.000 abstract 5
- 241000124008 Mammalia Species 0.000 abstract 4
- 239000003638 chemical reducing agent Substances 0.000 abstract 2
- 210000004051 gastric juice Anatomy 0.000 abstract 2
- 238000001727 in vivo Methods 0.000 abstract 2
- 239000007800 oxidant agent Substances 0.000 abstract 2
- 230000001590 oxidative effect Effects 0.000 abstract 2
- 238000006479 redox reaction Methods 0.000 abstract 2
- 210000002784 stomach Anatomy 0.000 abstract 2
- 239000003937 drug carrier Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/960,149 US5885592A (en) | 1997-10-29 | 1997-10-29 | Methods and pharmaceutical compositions for oral delivery of molecular iodine |
PCT/US1998/022720 WO1999021567A1 (en) | 1997-10-29 | 1998-10-27 | Pharmaceutical compositions for oral administration of molecular iodine |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE231725T1 true ATE231725T1 (de) | 2003-02-15 |
Family
ID=25502851
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98954002T ATE231725T1 (de) | 1997-10-29 | 1998-10-27 | Pharmazeutische zubereitungen zur oralen verabreichung von molekulares jod |
Country Status (17)
Country | Link |
---|---|
US (1) | US5885592A (de) |
EP (1) | EP1024815B1 (de) |
JP (1) | JP4187410B2 (de) |
KR (1) | KR100412219B1 (de) |
CN (1) | CN1150904C (de) |
AT (1) | ATE231725T1 (de) |
AU (1) | AU750627B2 (de) |
BR (1) | BR9812588A (de) |
CA (1) | CA2301503C (de) |
DE (1) | DE69811105T2 (de) |
DK (1) | DK1024815T3 (de) |
ES (1) | ES2191973T3 (de) |
IL (1) | IL134778A0 (de) |
NO (1) | NO20001673L (de) |
PT (1) | PT1024815E (de) |
RU (1) | RU2213564C2 (de) |
WO (1) | WO1999021567A1 (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6248335B1 (en) * | 1997-10-29 | 2001-06-19 | Symbollon Corporation | Stabilized oral pharmaceutical composition containing iodide and iodate and method |
WO1999034809A1 (fr) * | 1998-01-06 | 1999-07-15 | Fujisawa Pharmaceutical Co., Ltd. | Preparations solides a base d'iodophore et procede de fabrication correspondant |
DE69910210T2 (de) | 1998-06-19 | 2004-06-17 | Oxibio, Inc., Portland | Implantierbare medizinische vorrichtung mit antiinfektiösen und kontrazeptiven eigenschaften |
US6154672A (en) * | 1998-06-22 | 2000-11-28 | Pacesetter, Inc. | Method and apparatus for improving the probability of success of defibrillation shocks |
GB2395901A (en) * | 1999-02-26 | 2004-06-09 | Symbollon Corp | Stabilised tablets containing iodide and iodate |
PT1195178E (pt) * | 2000-10-06 | 2006-10-31 | Dmg Italia Srl | Preparacao imunotrofica para o tratamento da hipertrofia adenoamigdalar. |
ES2359818T3 (es) * | 2003-06-20 | 2011-05-27 | Hill's Pet Nutrition, Inc. | Métodos para hipertiroidismo en un gato y composición que comprende yodo limitado. |
US8501223B2 (en) * | 2003-06-20 | 2013-08-06 | Hill's Pet Nutrition, Inc. | Methods for dietary management of cats to avoid hyperthyroidism |
CA2823751C (en) * | 2006-01-26 | 2015-10-06 | Hill's Pet Nutrition, Inc. | Methods and compositions for treating feline hyperthyroidism |
CA2650845C (en) * | 2006-05-12 | 2015-07-07 | Hill's Pet Nutrition, Inc. | Compositions and methods for preventing or treating chronic renal failure in felines with hyperthyroidism |
US8303994B2 (en) * | 2006-06-22 | 2012-11-06 | Jack Howard Kessler | Method for the eradication of pathogens including S. aureus and antibiotic resistant microbes from the upper respiratory tract of mammals and for inhibiting the activation of immune cells |
CA2656608C (en) * | 2006-07-03 | 2014-09-16 | Hill's Pet Nutrition, Inc. | Compositions and methods for preventing or treating cardiovascular diseases in felines with hyperthyroidism |
US8226964B2 (en) * | 2006-09-07 | 2012-07-24 | Biolargo Life Technologies, Inc. | Systems and methods for cleaning liquid carriers related applications data |
US7943158B2 (en) * | 2006-09-07 | 2011-05-17 | BioLargo Life Technologies, Inc | Absorbent systems providing antimicrobial activity |
US8021610B2 (en) * | 2006-09-07 | 2011-09-20 | Biolargo Life Technologies, Inc. | Systems providing antimicrobial activity to an environment |
US7867510B2 (en) * | 2006-09-07 | 2011-01-11 | BioLargo Life Technologies, Inc | Material having antimicrobial activity when wet |
US9414601B2 (en) * | 2006-09-07 | 2016-08-16 | Biolargo Life Technologies, Incorporated | Material having antimicrobial activity when wet |
US20080063560A1 (en) * | 2006-09-07 | 2008-03-13 | Biolargo Life Technologies, Incorporated | Ground treatment for reducing microbial content |
US8257749B2 (en) * | 2007-02-08 | 2012-09-04 | Biolargo Life Technologies, Incorporated | Systems providing at least pesticidal activity |
WO2009087647A1 (en) * | 2008-01-07 | 2009-07-16 | Council Of Scientific & Industrial Research | A stabilized iodine-water concentrate formulation useful for protection against iodine deficiency disorders |
MX340005B (es) * | 2010-04-23 | 2016-05-18 | Univ Nac Autónoma De México | Composicion de yodo molecular de uso humano para la prevencion y tratamiento de patologias prostaticas. |
EP2606885B1 (de) * | 2011-05-16 | 2016-05-11 | Begaliev, Shokan Sabirkhanovich | Wiederherstellung eines arzneimittelpräparats mit antibakterieller, antiulzeröser und immunmodulierender wirkung |
CN102697804B (zh) * | 2012-06-07 | 2014-02-12 | 维尔信科技(潍坊)有限公司 | 一种固态分子碘消毒制剂及其制备方法 |
US10034899B2 (en) * | 2013-11-27 | 2018-07-31 | BioPharmX, Inc. | Solid oral dosage form for breast symptoms |
JP6573620B2 (ja) * | 2014-02-10 | 2019-09-11 | フレッド ハッチンソン キャンサー リサーチ センター | 心臓発作及び虚血損傷のハロゲン治療 |
WO2015153258A1 (en) | 2014-03-31 | 2015-10-08 | Iotech International, Llc | Stable compositions of uncomplexed iodine and methods of use |
EA031907B1 (ru) * | 2016-03-11 | 2019-03-29 | Тимур Хусаинович Измайлов | Шашка иодная дымовая |
WO2017185060A1 (en) | 2016-04-21 | 2017-10-26 | BioPharmX, Inc. | Oral iodine dosage form |
KR20190123716A (ko) | 2016-07-21 | 2019-11-01 | 아이오젠, 엘엘씨 | 연화성 국소 소독제 |
CN106727683A (zh) * | 2016-12-23 | 2017-05-31 | 刘海涛 | 一种药物制剂在制备治疗幽门螺杆菌感染性疾病的药物中的应用 |
TW202203900A (zh) * | 2020-03-31 | 2022-02-01 | 越南商泰明製藥股份有限公司 | 用於治療癌症、子宮內膜異位症以及癌症或子宮內膜異位症患者的疼痛之二異丙胺化合物以及碘 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2540170C3 (de) * | 1975-09-10 | 1979-01-18 | Basf Ag, 6700 Ludwigshafen | Verwendung von in organischer Lösung hergestelltem Polyvinylpyrrolidon zur Herstellung von stabilen wäßrigen PoIyvinylpyrrolidon-Jod-Lösungen |
US4259322A (en) * | 1978-03-20 | 1981-03-31 | Helong Lim | Method of treatment of tuberculosis |
US4187294A (en) * | 1978-07-06 | 1980-02-05 | Nihon Nousan Kougyou Co., Ltd. | Method for producing eggs containing a high amount of iodinated amino acids |
JPS5663919A (en) * | 1979-10-29 | 1981-05-30 | Nippon Nousan Kogyo Kk | Remedial composition for diabetes |
JPS57140723A (en) * | 1981-02-25 | 1982-08-31 | Nippon Nousan Kogyo Kk | Preventing composition for hyperlipemia due to neutral fat |
US5171582A (en) * | 1985-07-31 | 1992-12-15 | Ghent William R | Treatment of iodine deficiency diseases |
US5250304A (en) * | 1985-07-31 | 1993-10-05 | Ghent William R | Treatment of iodine deficiency diseases |
US5589198A (en) * | 1985-07-31 | 1996-12-31 | 943038 Ontario, Inc. | Treatment of iodine deficiency diseases |
US4816255A (en) * | 1985-07-31 | 1989-03-28 | Ghent William R | Treatment of iodine deficiency breast syndrome |
US5629024A (en) * | 1994-08-22 | 1997-05-13 | Symbollon Corporation | Method of forming an iodine based germicide composition |
-
1997
- 1997-10-29 US US08/960,149 patent/US5885592A/en not_active Expired - Lifetime
-
1998
- 1998-10-21 IL IL13477898A patent/IL134778A0/xx not_active IP Right Cessation
- 1998-10-27 WO PCT/US1998/022720 patent/WO1999021567A1/en active IP Right Grant
- 1998-10-27 ES ES98954002T patent/ES2191973T3/es not_active Expired - Lifetime
- 1998-10-27 DE DE69811105T patent/DE69811105T2/de not_active Expired - Lifetime
- 1998-10-27 KR KR10-2000-7003542A patent/KR100412219B1/ko not_active IP Right Cessation
- 1998-10-27 EP EP98954002A patent/EP1024815B1/de not_active Expired - Lifetime
- 1998-10-27 RU RU2000107852/14A patent/RU2213564C2/ru not_active IP Right Cessation
- 1998-10-27 JP JP2000517725A patent/JP4187410B2/ja not_active Expired - Fee Related
- 1998-10-27 AU AU11227/99A patent/AU750627B2/en not_active Ceased
- 1998-10-27 AT AT98954002T patent/ATE231725T1/de not_active IP Right Cessation
- 1998-10-27 PT PT98954002T patent/PT1024815E/pt unknown
- 1998-10-27 BR BR9812588-5A patent/BR9812588A/pt not_active Application Discontinuation
- 1998-10-27 CA CA002301503A patent/CA2301503C/en not_active Expired - Fee Related
- 1998-10-27 DK DK98954002T patent/DK1024815T3/da active
- 1998-10-27 CN CNB988097648A patent/CN1150904C/zh not_active Expired - Fee Related
-
2000
- 2000-03-31 NO NO20001673A patent/NO20001673L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2213564C2 (ru) | 2003-10-10 |
BR9812588A (pt) | 2000-07-25 |
WO1999021567A1 (en) | 1999-05-06 |
IL134778A0 (en) | 2001-04-30 |
CN1272789A (zh) | 2000-11-08 |
US5885592A (en) | 1999-03-23 |
CA2301503A1 (en) | 1999-05-06 |
ES2191973T3 (es) | 2003-09-16 |
JP4187410B2 (ja) | 2008-11-26 |
EP1024815B1 (de) | 2003-01-29 |
DE69811105D1 (de) | 2003-03-06 |
AU750627B2 (en) | 2002-07-25 |
DE69811105T2 (de) | 2003-11-06 |
CA2301503C (en) | 2005-01-04 |
NO20001673D0 (no) | 2000-03-31 |
NO20001673L (no) | 2000-05-24 |
AU1122799A (en) | 1999-05-17 |
CN1150904C (zh) | 2004-05-26 |
JP2003510243A (ja) | 2003-03-18 |
EP1024815A1 (de) | 2000-08-09 |
KR20010030861A (ko) | 2001-04-16 |
DK1024815T3 (da) | 2003-05-19 |
KR100412219B1 (ko) | 2003-12-24 |
PT1024815E (pt) | 2003-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE231725T1 (de) | Pharmazeutische zubereitungen zur oralen verabreichung von molekulares jod | |
PL350658A1 (en) | Medical preparations for the treatment of alpha−galactosidase a deficiency | |
ATE306266T1 (de) | Verbesserte verabreichungstechnik für multiple medikamentengaben | |
IL208184A0 (en) | Glp-1, and methods for treating diabetes | |
ATE319447T1 (de) | Pharmazeutische zubereitungen die clavulansäure oder derivate enthalten zur behandlund von neurologischen störungen | |
ATE277594T1 (de) | Vorrichtungen um eine verlängerte medikamententherapie zu erreichen | |
DE60324427D1 (de) | Verfahren zur modulation der tubulindeacetylase-aktivität | |
TR200103613T2 (tr) | Burun içinden tatbik edilen morfini içeren farmasötik formülasyonlar ve yöntemler. | |
PL345959A1 (en) | Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate | |
DE69619052D1 (de) | Feste, wasserfreie, pharmazeutische Zubereitungen für vaginale Verwendung | |
UA32457C2 (uk) | Лікарський засіб (варіанти) і спосіб медикаментозного впливу на організм | |
PT1007055E (pt) | Utilizacao de amifostina | |
DK0996462T3 (da) | Farmaceutiske kombinationspræparater indeholdende erythropoietin og modificerede hæmoglobiner | |
CA2032475A1 (en) | Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines | |
DE60222383D1 (de) | Medikament zur verabreichung von amifostin und verwandten wirkstoffen | |
AU1656997A (en) | Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer | |
EP0835662A3 (de) | Arzneimittel zur Behandlung von Krebs | |
EP1073436A4 (de) | Verbesserte methode zur ausrottung von helicobacter pylori | |
EP0271151A3 (de) | Azumolen-Dosisformen | |
DK1019066T3 (da) | Fremgangsmåder og præparater til forebyggelse og behandling af halsbrand | |
CA2197139A1 (en) | A drug for the treatment of cancer | |
RU97101420A (ru) | Способ лечения тонзиллита | |
HK1056117A1 (en) | Treatment of hepatitis C with thymosin and pegylated interferon | |
RU97110400A (ru) | Способ профилактики и лечения больных, страдающих эстрогенно- и андрогенозависимыми опухолями | |
RU97104198A (ru) | Способ лечения респираторного дистресс-синдрома |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1024815 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |